browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
4e3bee68-057c-4990-b1ea-bb2bde1d2e90
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 17:10:21
Income (reported)
$40,000
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

FORBES-TATE

Government Relations Firm.

Contact
ZACHARY WILLIAMS
Phone
+1 202-638-0125
Address
zip:20001, city:Washington, state:DC, street:777 6th Street NW 8th Floor
Client

INDEPENDENT PHARMACY COOPERATIVE

Largest group purchasing organization for independent pharmacies.

State
WI
Country
US
Government-entity client
false
Effective date
2016-01-01
Issues lobbied + lobbyists (5)

HCR — Health Issues

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

PHA — Pharmacy

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

BUD — Budget/Appropriations

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation Program in the One Big Beautiful Bill Act (P.L. 119-21).

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

CSP — Consumer Issues/Safety/Products

Issues related to S.3822 - Break Up Big Medicine Act.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.